fda halts glp-1 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Breaking: ProRx is halting production

These peptides come with a Certificate of Analysis (COA)confirmed by thirdparty testingverifying 99% purity and batch potency

To better mimic the complexity of the human brain, we differentiated brain organoids from iPSC of PSEN1-9 (depicted as AD-cBOs) and corresponding isogenic lines (depicted as Iso-cBOs) and studied whether ferroptosis-related proteins were altered in AD organoids

One side effect is dry mouth and bad breath, which is described as a rotten egg-like odor

Labs are repeated at 812 weeks to objectively measure hormonal and metabolic changes

EVALUACIONES MENSUALES Once you have come to the end of your vial, it is time for a virtual re-evaluation